Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Semaglutide (known by its brandname Ozempic) has gained widespread attention ... data on its risks and benefits for those with type 1 diabetes, new research offers promising insights.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated between the government and manufacturers.

WASHINGTON — (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been ... generate about $6 billion for taxpayers and $1.5 billion for Medicare enrollees.

According to NVO, the 7.2 mg version was safe and had a well-tolerated profile in the study. The company added that, as expected from the GLP-1 class of drugs, most of the adverse events linked to ...

WASHINGTON (AP) — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...

WASHINGTON (AP) — Biden administration selects 15 new medications up for price negotiations including weight loss drugs Ozempic and Wegovy.